Independent medication-format guide
Tirzepatide Pill in 2026: Oral Tablets, Cost, and FDA Status
A current consumer guide to tirzepatide pill searches, FDA-approved tirzepatide injections, compounded oral tablets, online access, pricing, alternatives, and questions to verify before paying.
Does tirzepatide come in a pill form?
You can find products marketed online as tirzepatide pills, oral tirzepatide, or tirzepatide tablets. That does not mean FDA has approved an oral Zepbound or Mounjaro tablet.
As of August 8, 2026, FDA labeling results for both Zepbound and Mounjaro list tirzepatide as injection, solution with a subcutaneous route. Care Path Compare did not identify an FDA-approved oral tirzepatide tablet in those current labeling records.
The main distinction is therefore:
- FDA-approved tirzepatide: branded injectable products with product-specific labeling and evidence.
- Compounded tirzepatide tablet: a non-FDA-approved compounded preparation that must be evaluated on its own formulation, pharmacy, prescription, evidence, and commercial terms.
Tirzepatide pill options at a glance
| Pathway | Current status | Oral? | What to verify |
|---|---|---|---|
| Zepbound | FDA-approved branded tirzepatide for labeled uses | No; current labeling lists subcutaneous injection | Prescription, dose, coverage, savings, pharmacy route |
| Mounjaro | FDA-approved branded tirzepatide for labeled uses | No; current labeling lists subcutaneous injection | Prescription, indication, dose, coverage, pharmacy route |
| Compounded tirzepatide tablet | Not FDA-approved | Yes, when prescribed and compounded in tablet form | Exact formulation, evidence, pharmacy, price, renewal, refund terms |
| Wegovy pill | FDA-approved oral semaglutide, not tirzepatide | Yes | Whether semaglutide is appropriate, current price, administration rules |
| Foundayo | FDA-approved oral orforglipron, not tirzepatide | Yes | Whether orforglipron is appropriate, strength, price, coverage |
The oral alternatives in this table are not tirzepatide substitutes or equivalents. They are different prescription products that a licensed clinician may or may not consider appropriate.
Can you get a tirzepatide pill online?
Some telehealth companies currently advertise compounded tirzepatide tablets after clinician review. Online availability does not establish FDA approval, eligibility, a prescription, pharmacy fulfillment, or clinical appropriateness.
SkinnyRx currently lists a once-daily compounded tirzepatide tablet from $299 per month. Its public process describes an online assessment followed by licensed-clinician review; fulfillment occurs only if a prescription is issued and the pathway is available for the patient.
Review SkinnyRx’s Current Compounded Tirzepatide Tablet Pathway
Affiliate disclosure: Care Path Compare may receive compensation if you use the SkinnyRx link and make a purchase, at no extra cost to you. Compensation does not change our conclusion that this is a compounded product and not an FDA-approved Zepbound or Mounjaro pill.
Is a compounded tirzepatide tablet FDA-approved?
No. A compounded tirzepatide tablet is not an FDA-approved finished drug product.
FDA says compounded drugs are not reviewed before marketing for safety, effectiveness, or quality in the same way as approved drugs. FDA has also cautioned telehealth companies not to describe compounded GLP-1 drugs as approved generics, the same as approved drugs, or clinically proven to produce the same results.
A licensed clinician may determine that a compounded prescription is appropriate in a particular situation, but that medical decision does not convert the compounded product into an FDA-approved drug.
Do tirzepatide pills work the same as Zepbound or Mounjaro injections?
That should not be assumed.
Evidence from an approved injectable product belongs to the product, route, formulation, dose, and study conditions that were actually evaluated. A compounded tablet may differ in formulation and absorption, and injectable trial results should not automatically be used to predict the effect of an oral compounded preparation.
Before considering a compounded oral product, ask what evidence supports that exact formulation and route, not merely whether the ingredient name tirzepatide appears on the label or marketing page.
Useful questions include:
- What is the exact dosage form and administration route?
- What evidence applies to this exact compounded preparation?
- Which pharmacy compounds and dispenses it?
- What ingredients or excipients are used?
- What instructions accompany the prescription?
- How does the prescriber handle response, side effects, dose questions, and refills?
How much do tirzepatide pills cost?
SkinnyRx currently advertises compounded tirzepatide tablets from $299 per month. The same homepage also advertises compounded injectable tirzepatide from $299 per month.
A matching headline price does not make the tablet and injection equivalent products. Before paying, verify:
- the amount charged today;
- the normal renewal amount;
- whether price changes with the prescribed dose or formulation;
- whether a promotional or prepaid commitment is required;
- whether clinician review, shipping, supplies, and follow-up are included;
- the point at which the order becomes nonrefundable; and
- the legal name and location of the dispensing pharmacy.
For the broader billing and refund context, see our SkinnyRx cost guide.
What oral alternatives exist if you want to avoid injections?
A person searching for a “tirzepatide pill” may ultimately be looking for an FDA-approved oral weight-management option, not necessarily tirzepatide itself.
Current oral products include:
- Wegovy pill, which contains semaglutide and is not tirzepatide.
- Foundayo, which contains orforglipron and is not tirzepatide.
- Other oral drugs with different labeling and indications that a clinician may consider depending on the situation.
Those products should be compared on their own FDA status, active ingredient, labeled use, instructions, contraindications, price, coverage, and clinician assessment. They are not oral versions of Zepbound or Mounjaro.
See our oral GLP-1 options comparison for the broader decision framework.
Tirzepatide pill versus injection
| Factor | Compounded tirzepatide tablet | FDA-approved branded tirzepatide injection |
|---|---|---|
| Route | Oral tablet as prescribed | Subcutaneous injection |
| FDA approval | No | Yes, for the approved product and labeled use |
| Evidence | Exact compounded formulation must be assessed on its own | Product-specific clinical and labeling evidence |
| Dosing routine | Prescription and pharmacy specific | Product-label specific |
| Pharmacy | Compounding and dispensing route must be verified | Standard prescription fulfillment route varies |
| Cost | Telehealth and pharmacy specific | Coverage, savings, dose, pharmacy, and cash-pay route specific |
| Automatically interchangeable? | No | No automatic substitution with a compounded tablet |
Avoiding injections is a legitimate practical preference to discuss with a clinician, but it does not establish that a compounded oral tirzepatide product is equivalent or medically appropriate.
SkinnyRx warning-letter context
FDA sent Lean Rx, Inc. dba SkinnyRx a warning letter dated February 20, 2026 concerning website representations about compounded semaglutide and tirzepatide products. FDA cited, among other issues, claims and imagery that it said falsely or misleadingly implied sameness with FDA-approved products or suggested SkinnyRx was the compounder.
A warning letter gives a company an opportunity to respond and take corrective action. Care Path Compare did not locate an FDA close-out letter for this matter in its August 8, 2026 review, so we describe the letter as documented regulatory history rather than assuming either unresolved violations or formal closure.
When reviewing the current pathway, verify that the live offer clearly states:
- that the tablet is compounded;
- that it is not generic Zepbound or generic Mounjaro;
- that injectable trial evidence is not presented as proof of tablet equivalence;
- who makes the prescribing decision;
- which pharmacy will dispense the prescription; and
- the recurring price and refund cutoff.
How to evaluate a tirzepatide pill website
Before entering payment details, look for clear answers to these questions:
- Does the page explicitly say whether the product is compounded?
- Does it identify the dosage form and route?
- Does it avoid calling the product FDA-approved tirzepatide when it is compounded?
- Does it avoid calling the product generic Zepbound or Mounjaro?
- Who is the licensed clinician making the prescribing decision?
- Which pharmacy compounds or dispenses the prescription?
- Is that pharmacy licensed to serve your state?
- What is due today and at renewal?
- What event makes the purchase nonrefundable?
- What support is available for side effects, refill questions, and changes in treatment?
Frequently asked questions
Does tirzepatide come in pill form?
Current FDA labeling lists Zepbound and Mounjaro tirzepatide as subcutaneous injections, not oral tablets. Compounded tirzepatide tablets are advertised by some telehealth companies, but those products are not FDA-approved oral Zepbound or Mounjaro.
Is there an oral Zepbound pill?
Care Path Compare did not identify an FDA-approved oral Zepbound product in current FDA labeling as of August 8, 2026. Zepbound is currently listed as a tirzepatide injection.
Can I buy tirzepatide pills online?
Some telehealth companies advertise compounded tirzepatide tablets through an online intake and clinician-review process. A website checkout does not guarantee eligibility, prescribing, pharmacy fulfillment, or availability in every state.
How much is a tirzepatide pill?
SkinnyRx currently advertises its compounded tirzepatide tablet pathway from $299 per month. Confirm the live checkout amount, renewal price, prescription details, pharmacy, and refund cutoff before paying.
Are tirzepatide tablets FDA-approved?
The compounded tirzepatide tablets discussed on this page are not FDA-approved finished drug products. Current Zepbound and Mounjaro labeling lists tirzepatide as a subcutaneous injection.
Is oral tirzepatide the same as Mounjaro?
No. Mounjaro is an FDA-approved branded tirzepatide injection. A compounded oral tirzepatide preparation is a different product category and should not be described as generic or equivalent Mounjaro.
What if I want a weight-loss pill instead of an injection?
Ask a licensed clinician about current FDA-approved oral options and other treatment approaches. Wegovy pill and Foundayo are oral products, but neither is tirzepatide and neither should be treated as an oral Zepbound or Mounjaro equivalent.
Check SkinnyRx’s Current Tirzepatide Tablet Offer
Affiliate disclosure: Care Path Compare may receive compensation if you use the SkinnyRx link and make a purchase, at no extra cost to you. Affiliate compensation does not determine our FDA-status distinctions, safety framing, or editorial conclusions.
Next steps
Compare oral GLP-1 options, review pill versus injection formats, or read our SkinnyRx tirzepatide review before beginning an intake.
Important information
Official sources
- U.S. Food and Drug Administration, current labeling results for Zepbound, accessed August 8, 2026.
- U.S. Food and Drug Administration, current labeling results for Mounjaro, accessed August 8, 2026.
- U.S. Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, accessed August 8, 2026.
- U.S. Food and Drug Administration, FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs, accessed August 8, 2026.
- SkinnyRx, compounded tirzepatide tablet page and current weight-care homepage, accessed August 8, 2026.
- U.S. Food and Drug Administration, Lean Rx, Inc. dba SkinnyRx warning letter dated February 20, 2026, reviewed August 8, 2026.